{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T13:27:50Z","timestamp":1777210070555,"version":"3.51.4"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.phrs.2016.07.041","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T21:25:56Z","timestamp":1469741156000},"page":"652-658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Hydrogen sulfide-releasing anti-inflammatory drugs for chemoprevention and treatment of cancer"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2520-9647","authenticated-orcid":false,"given":"Angela","family":"Ianaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Cirino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.07.041_bib0005","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1152\/physrev.00004.2008","article-title":"Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn\u2ffft the stomach digest itself?","volume":"88","author":"Wallace","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2016.07.041_bib0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archinte.159.2.161","article-title":"Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study","volume":"159","author":"Smalley","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.phrs.2016.07.041_bib0015","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1470-2045(02)00680-0","article-title":"Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention","volume":"3","author":"Chan","year":"2002","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phrs.2016.07.041_bib0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrc1801","article-title":"Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics","volume":"6","author":"Ulrich","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2016.07.041_bib0025","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/gut.2009.203000","article-title":"Effect of aspirin and NSAIDs on risk and survival from colorectal cancer","volume":"59","author":"Din","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2016.07.041_bib0030","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3748\/wjg.v19.i12.1861","article-title":"Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy","volume":"19","author":"Wallace","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2016.07.041_bib0035","first-page":"115","article-title":"Chemoprevention of cancers in gastrointestinal tract with cyclooxygenase 2 inhibitors","volume":"19","author":"Wang","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2016.07.041_bib0040","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJMoa061355","article-title":"Celecoxib for the prevention of sporadic colorectal adenomas","volume":"355","author":"Bertagnolli","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.07.041_bib0045","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa061652","article-title":"Celecoxib for the prevention of colorectal adenomatous polyps","volume":"355","author":"Arber","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.07.041_bib0050","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.bjp.0706201","article-title":"Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense","volume":"145","author":"Wallace","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.07.041_bib0055","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.07.041_bib0060","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.amjmed.2008.06.035","article-title":"Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injury","volume":"121","author":"Winkelmayer","year":"2008","journal-title":"Am. J. Med."},{"key":"10.1016\/j.phrs.2016.07.041_bib0065","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrd4433","article-title":"Hydrogen sufide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter","volume":"14","author":"Wallace","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2016.07.041_bib0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1089\/ars.2011.4351","article-title":"Hydrogen sulfide: an endogenous mediator of resolution of inflammation and injury","volume":"17","author":"Wallace","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2016.07.041_bib0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/ars.2011.4345","article-title":"Hydrogen sulfide is a signaling molecule and a cytoprotectant","volume":"17","author":"Kimura","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2016.07.041_bib0080","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1096\/fj.07-8669com","article-title":"Hydrogen sulfide enhances ulcer healing in rats","volume":"21","author":"Wallace","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2016.07.041_bib0085","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1053\/j.gastro.2009.04.012","article-title":"Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats","volume":"137","author":"Wallace","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2016.07.041_bib0090","doi-asserted-by":"crossref","first-page":"e71962","DOI":"10.1371\/journal.pone.0071962","article-title":"Enhanced synthesis and diminished degradation of hydrogen sulfide in experimental colitis: a site-specific, pro-resolution mechanism","volume":"8","author":"Flannigan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.07.041_bib0095","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/j.gastro.2005.07.060","article-title":"Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs","volume":"129","author":"Fiorucci","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2016.07.041_bib0100","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/s10620-012-2051-5","article-title":"Gastroprotective effect of NaHS against mucosal lesions induced by ischemia-reperfusion injury in rat","volume":"57","author":"Mard","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.phrs.2016.07.041_bib0105","doi-asserted-by":"crossref","first-page":"e110688","DOI":"10.1371\/journal.pone.0110688","article-title":"Cytoprotective effects of hydrogen sulfide in novel rat models of non-erosive esophagitis","volume":"9","author":"Zayachkivska","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.07.041_bib0110","doi-asserted-by":"crossref","first-page":"e0118972","DOI":"10.1371\/journal.pone.0118972","article-title":"Endogenous prostaglandins and afferent sensory nerves in gastroprotective effect of hydrogen sulfide against stress-induced gastric lesions","volume":"10","author":"Magierowski","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.07.041_bib0115","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1096\/fj.07-8669com","article-title":"Hydrogen sulfide enhances ulcer healing in rats","volume":"21","author":"Wallace","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2016.07.041_bib0120","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1096\/fj.06-6270fje","article-title":"Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation","volume":"20","author":"Zanardo","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2016.07.041_bib0125","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1089\/ars.2014.5901","article-title":"Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics","volume":"22","author":"Wallace","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2016.07.041_bib0130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1124\/jpet.105.091595","article-title":"Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels","volume":"316","author":"Distrutti","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.07.041_bib0135","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.1021\/jm901638j","article-title":"Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals","volume":"53","author":"Caliendo","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2016.07.041_bib0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2006.11.042","article-title":"Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulphide-releasing diclofenac derivative in the rat","volume":"132","author":"Wallace","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2016.07.041_bib0145","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1476-5381.2009.00611.x","article-title":"Markedly reduced toxicity of a hydrogen sulfide-releasing derivative of naproxen (ATB-346)","volume":"159","author":"Wallace","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.07.041_bib0150","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1749-6632.2010.05556.x","article-title":"Detection of hydrogen sulfide in plasma and knee-joint synovial fluid from rheumatoid arthritis patients: relation to clinical and laboratory measures of inflammation","volume":"1203","author":"Whiteman","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.phrs.2016.07.041_bib0155","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.freeradbiomed.2006.12.011","article-title":"Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative","volume":"42","author":"Li","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2016.07.041_bib0160","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/jnci\/51.3.1029","article-title":"Pathology of intestinal neoplasms and other lesions in rats exposed to azoxymethane","volume":"51","author":"Ward","year":"1973","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.phrs.2016.07.041_bib0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3835(87)90157-1","article-title":"Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings","volume":"37","author":"Bird","year":"1987","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2016.07.041_bib0170","doi-asserted-by":"crossref","first-page":"PL367","DOI":"10.1016\/S0024-3205(98)00191-X","article-title":"Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma","volume":"62","author":"Bak","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2016.07.041_bib0175","doi-asserted-by":"crossref","first-page":"G860","DOI":"10.1152\/ajpgi.00330.2009","article-title":"R-flurbiprofen suppresses distal nonmucin-producing colorectal tumors in azoxymethane-treated rats, without suppressing eicosanoid production","volume":"298","author":"Martin","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.phrs.2016.07.041_bib0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.niox.2014.04.006","article-title":"Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer","volume":"41","author":"Elsheikh","year":"2014","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.phrs.2016.07.041_bib0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.niox.2014.11.010","article-title":"H2S-releasing drugs: anti-inflammatory, cytoprotective and chemopreventive potential","volume":"46","author":"Gemici","year":"2015","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.phrs.2016.07.041_bib0190","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00008469-200608000-00005","article-title":"Chemopreventive potential of diallylsulfide, lycopene and theaflavin during chemically induced colon carcinogenesis in rat colon through modulation of cyclooxygenase-2 and inducible nitric oxide synthase pathways","volume":"15","author":"Sengupta","year":"2006","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.phrs.2016.07.041_bib0195","unstructured":"Wallace J.L., Cirino G., Santagada V., Caliendo G., Hydrogen sulfide derivatives of nonsteroidal anti-inflammatory drugs, United States Patent Application No. WO\/2008\/009127 (2008)."},{"key":"10.1016\/j.phrs.2016.07.041_bib0200","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.bjp.0707193","article-title":"Enhanced activity of a hydrogen sulphide releasing derivative of mesalamine (ATB-429) in a mouse model of colitis","volume":"150","author":"Fiorucci","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.07.041_bib0205","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/bph.12961","article-title":"Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota","volume":"172","author":"Blackler","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.07.041_bib0210","doi-asserted-by":"crossref","first-page":"G994","DOI":"10.1152\/ajpgi.00066.2015","article-title":"Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID","volume":"308","author":"Blackler","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.phrs.2016.07.041_bib0215","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/MIB.0000000000000345","article-title":"Hydrogen sulfide protects from colitis and restores intestinal microbiota biofilm and mucus production","volume":"21","author":"Motta","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.phrs.2016.07.041_bib0220","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.07.041_bib0225","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1126\/science.2296722","article-title":"A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse","volume":"247","author":"Moser","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.phrs.2016.07.041_bib0230","doi-asserted-by":"crossref","first-page":"e0147289","DOI":"10.1371\/journal.pone.0147289","article-title":"Profound chemopreventative effects of a hydrogen sulfide-releasing NSAID in the APCMin\/+ mouse model of intestinal tumorigenesis","volume":"11","author":"Paul-Clark","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.07.041_bib0235","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.7314\/APJCP.2012.13.4.1115","article-title":"Modifying effect of diallyl sulfide on colon carcinogenesis in C57BL\/6J-ApcMin\/+ mice","volume":"13","author":"Kange","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.phrs.2016.07.041_bib0240","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-1119(96)00589-6","article-title":"Structural chromosomal localization and expression of mouse genes encoding type III Reg, RegIII alpha, RegIII beta, RegIII gamma","volume":"185","author":"Narushima","year":"1997","journal-title":"Gene"},{"key":"10.1016\/j.phrs.2016.07.041_bib0245","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2172-11-39","article-title":"Changes in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species","volume":"11","author":"Barnett","year":"2010","journal-title":"BMC Immunol."},{"key":"10.1016\/j.phrs.2016.07.041_bib0250","doi-asserted-by":"crossref","first-page":"e35196","DOI":"10.1371\/journal.pone.0035196","article-title":"Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence","volume":"7","author":"Blackler","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.07.041_bib0255","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cdp.2008.08.002","article-title":"Bioinformatics approach to mRNA markers discovery for detection of circulating tumor cells in patients with gastrointestinal cancer","volume":"32","author":"Valladares-Ayerbes","year":"2008","journal-title":"Cancer Detect. Prev."},{"key":"10.1016\/j.phrs.2016.07.041_bib0260","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/(SICI)1097-0215(19990531)81:5<688::AID-IJC3>3.0.CO;2-R","article-title":"Pap, reg Ialpha and reg Ibeta mRNAs are concomitantly up-regulated during human colorectal carcinogenesis","volume":"81","author":"Rechreche","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phrs.2016.07.041_bib0265","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1054\/bjoc.2000.1227","article-title":"Death from early colorectal cancer is predicted by the presence of transcripts of the REG gene family","volume":"83","author":"Macadam","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phrs.2016.07.041_bib0270","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cdp.2007.07.003","article-title":"Identification of gene signatures for invasive colorectal tumor cells","volume":"31","author":"Wiese","year":"2007","journal-title":"Cancer Detect. Prev."},{"key":"10.1016\/j.phrs.2016.07.041_bib0275","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/rr73","article-title":"Collaborative interactions between neutrophil elastase and metalloproteinases in extracellular matrix degradation in three-dimensional collagen gels","volume":"2","author":"Zhu","year":"2001","journal-title":"Respir. Res."},{"key":"10.1016\/j.phrs.2016.07.041_bib0280","first-page":"4873","article-title":"Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-\u03baB signaling","volume":"9","author":"Kodela","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.phrs.2016.07.041_bib0285","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.bcp.2011.12.018","article-title":"Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect","volume":"83","author":"Chattopadhyay","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2016.07.041_bib0290","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/ars.2013.5308","article-title":"Anti-cancer activity of new designer hydrogen sulfide-donating hybrids","volume":"20","author":"Kashfi","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2016.07.041_bib0295","doi-asserted-by":"crossref","first-page":"e21077","DOI":"10.1371\/journal.pone.0021077","article-title":"The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.07.041_bib0300","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/1535-7163.MCT-15-0691-T","article-title":"Fast hydrogen sulfide-releasing donor increases the tumor response to radiotherapy","volume":"15","author":"De Preter","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phrs.2016.07.041_bib0305","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1089\/ars.2012.4645","article-title":"Hydrogen sulfide protects against cellular senescence via S-sulfydration of Keap1 and activation of Nrf2","volume":"18","author":"Yang","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2016.07.041_bib0310","first-page":"504230","article-title":"The proapoptotic effect of traditional and novel nonsteroidal anti-inflammatory drugs in mammalian and yeast cells","author":"Farrugia","year":"2013","journal-title":"Oxid. Med. Cell. Longevity"},{"issue":"66","key":"10.1016\/j.phrs.2016.07.041_bib0315","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","author":"Siegel","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.phrs.2016.07.041_bib0320","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","article-title":"Cyclooxygenase-dependent tumor growth through evasion of immunity","volume":"162","author":"Zelenay","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2016.07.041_bib0325","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1007\/s10620-013-2777-8","article-title":"Polypharmacy of osteoarthritis: the perfect intestinal storm","volume":"58","author":"Wallace","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.phrs.2016.07.041_bib0330","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomized trials","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2016.07.041_bib0335","unstructured":"E. Panza, G. Ercolano, C. Armogida, G. Sessa, G. Pirozzi, G. Cirino, J.L. Wallace, A. Ianaro, ATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo, Pharmacol. Res. in press."},{"key":"10.1016\/j.phrs.2016.07.041_bib0340","first-page":"3157","article-title":"Development of a new melanoma model in C57BL\/6 mice","volume":"42","author":"Berkelhammer","year":"1982","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2016.07.041_bib0345","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1189\/jlb.72.1.9","article-title":"Role of CXCL1 in tumorigenesis of melanoma","volume":"72","author":"Dhawan","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.phrs.2016.07.041_bib0350","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1038\/onc.2011.160","article-title":"Raf kinases in cancer\u2fffRoles and therapeutic opportunities","volume":"30","author":"Maurer","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2016.07.041_bib0355","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/pcmr.12312","volume":"28","author":"Panza","year":"2015","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.phrs.2016.07.041_bib0360","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2016.07.041_bib0365","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations","volume":"367","author":"Flaherty","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.07.041_bib0370","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1074\/jbc.M312044200","article-title":"Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP)","volume":"279","author":"Dan","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.07.041_bib0375","doi-asserted-by":"crossref","first-page":"12474","DOI":"10.1073\/pnas.1306241110","article-title":"Tumor-derived hydrogen sulfide, produced by cystathionine-\u03b2-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer","volume":"110","author":"Szabo","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.07.041_bib0380","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1089\/ars.2014.5933","article-title":"The therapeutic potential of cystathionine \u03b2-synthase\/hydrogen sulfide inhibition in cancer","volume":"22","author":"Hellmich","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2016.07.041_bib0385","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.niox.2014.03.001","article-title":"Effect of S-adenosyl-L-methionine (SAM), an allosteric activator of cystathionine \u03b2-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro","volume":"41","author":"M\u00f3dis","year":"2014","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.phrs.2016.07.041_bib0390","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.4161\/cc.26064","article-title":"Endogenously produced hydrogen sulfide supports tumor cell growth and proliferation","volume":"12","author":"Szabo","year":"2013","journal-title":"ABBV Cell Cycle"},{"key":"10.1016\/j.phrs.2016.07.041_bib0395","doi-asserted-by":"crossref","first-page":"21972","DOI":"10.1073\/pnas.0908047106","article-title":"Hydrogen sulfide is an endogenous stimulator of angiogenesis","volume":"106","author":"Papapetropoulos","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.07.041_bib0400","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrd.2015.1","article-title":"Gasotransmitters in cancer: from pathophysiology to experimental therapy","volume":"15","author":"Szabo","year":"2015","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816304467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816304467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T11:31:13Z","timestamp":1692444673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816304467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":80,"alternative-id":["S1043661816304467"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.07.041","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrogen sulfide-releasing anti-inflammatory drugs for chemoprevention and treatment of cancer","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.07.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}